Covered $arna 2.03

Short initial $ARNA 2.05, only 2k shares, keeping pstns small and nimble.

Out $PPHM 1.07, conserving cash. Watching $ARNA for possible pop and short.

So $arna wantsto keep share price shiny happy through those conferences I'd imagine.

$arna didn't get a panel slot, but it's got 2 presentations at investor conferences. Mmmm hmmm.

FDA officially schedules obesity AdCom 3/28-3/29/12. As expected $ARNA will not be on the agenda. CV risks& studies http://t.co/z3SrqMsT

Orexigen surges on FDA trial pact for troubled weight loss drug - FierceBiotech - http://t.co/BAuKPtdo $OREX $VVUS $ARNA

MT @Gekkowire: BTW $ARNA lobbies as well --> http://t.co/VlwaQ3E4

@adamfeuerstein @BioDueDiligence And what scientific proof leads you to that conclusion? Or is your proof corruption and politics? $ARNA

@adamfeuerstein @BioDueDiligence @matthewherper Please point out the specific valvulopathy issues w/ $ARNA. Can't seem to find them. Thanks.

$ARNA looking for nice gap.